ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Esophageal Cancer

Esophageal Cancer

Use of the EGFR inhibitor cetuximab with chemoradiation did not improve survival in patients with esophageal carcinoma compared with chemoradiation alone, according to the results of the phase III RTOG 0436 trial.

This video reviews the use of endoscopic therapy for the management of Barrett esophagus and early esophageal cancer.

Nurse practitioners play a central role in helping patients with esophageal cancer understand and manage their disease and treatment complications.

A novel calculator can more easily identify which esophageal adenocarcinoma patients derive an overall survival benefit from neoadjuvant chemoradiation to help guide treatment choices.

Overweight individuals in early adulthood who gained additional weight to become obese later in life are at an increased risk for esophageal and gastric cardia adenocarcinomas.

Ahead of the 2017 ASCO Gastrointestinal Cancer Symposium in San Francisco, we spoke with Dr. Geoffrey Ku on the advances in systemic therapy for esophageal and gastric cancer.

Using PET scans during induction chemotherapy for esophageal cancer, researchers were able to assess patient response to treatment and adjust their therapy, leading to an improved rate of pathologic complete response prior to surgery.

Pages

Subscribe to Esophageal Cancer on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.